Castillo/Werner-
McCullough:FYCalculatingFYDrugFYDosages3rde,FY3rde
1
,Castillo/Werner-
McCullough:FYCalculatingFYDrugFYDosages3rde,FY3rde
2
,Castillo/Werner-
McCullough:FYCalculatingFYDrugFYDosages3rde,FY3rde
ChapterFY1:FYSafetyFYinFYMedicationFYAdministration
Castillo:FYCalculatingFYDrugFYDosages:FYAFYPatient-
SafeFYApproachFYtoFYNursingFYandFYMathFY3rdFYEdition
MULTIPLEFYCHOICE
1. TheFYfollowingFYmedicationFYorderFYisFYinFYtheFYpatient’sFYmedicationFYadministrationFYrecordFY(MA
R):
methylPREDnisoloneFY40FYmgFYPOFYdailyFYatFY0900.
AfterFYreadingFYtheFYorder,FYtheFYnurseFYcorrectlyFYdetermines:
A “PO”FYisFYanFYinappropriateFYabbreviation.
B theFYmedicationFYorderFYisFYwrittenFYcorrectly.
C 40FYmgFYshouldFYbeFYwrittenFYasFY40mg.
D tallFYmanFYletteringFYindicatesFYthatFYtheFYdrugFYisFYaFYnarc
otic.
ANSWER:FYB
Feedback
TheFYmedicationFYorderFYhasFYallFYtheFYrequiredFYcomponentsFY(drugFYname,FYdose,FYro
ute,FYandFYfrequencyFYofFYadministration)FYforFYaFYdrugFYorder.FY“PO”FYisFYanFYappropria
teFYabbreviation;FY40FYmgFYisFYwrittenFYcorrectlyFYwithFYaFYspaceFYbetweenFYtheFYdoseFYa
ndFYtheFYunitFYofFYmeasurement.FYTallFYmanFYletteringFYisFYusedFYtoFYdistinguishFYtheFYd
rugFYfromFYanotherFYdrug
withFYaFYsimilarFYname.
2. WhichFYofFYtheFYfollowingFYaccuratelyFYdescribesFYtheFY“BoxedFYWarning”FYfoundFYonFYaFYdrugFYlabel
?
A ItFYisFYprimarilyFYisFYusedFYtoFYidentifyFYtheFYsafeFYdoseFYforFYtheFYpatient.
B ItFYisFYcommonlyFYfoundFYonFYallFYdrugFYlabels.
C ItFYidentifiesFYseriousFYpotentialFYrisksFYandFYsideFYeffectsFYrelatedFYtoFYdrugFY
use.
D ItFYprotectsFYtheFYpatientFYbyFYprovidingFYinformationFYtoFYdecreaseFYsideFYef
fects.
ANSWER:FYC
Feedback
3
, Castillo/Werner-
McCullough: FYCalculatingFYDrugFYDosages3rde,FY3rde
AFYdrug FYlabelFYwithFYaFYboxedFYwarningFYprovidesFYinformationFYtoFYhealthcareFYprofe
ssionalsFYandFYpatientsFYregardingFYtheFYseriousFYrisksFYandFYsideFYeffectsFYrelatedFYtoFYth
eFYdrug.FYTheFYBoxedFYWarningFYisFYnotFYtheFYprimaryFYsourceFYforFYidentifyingFYtheFYp
atient’sFYdrugFYdosage.
TheFYwarningFYisFYfoundFYonFYspecificFYprescriptionFYmedicationsFYandFYdoesFYnotFY
provideFYinformationFYtoFYreduceFYorFYdecreaseFYsideFYeffects.
3. WhenFYpracticingFYsafetyFYinFYtheFYadministrationFYofFYmedication,FYforFYwhichFYofFYtheFYf
ollowingFYmedicationFYordersFYshouldFYaFYnurseFYseekFYclarificationFYbeforeFYtheFYadminist
rationFYofFYtheFYmedication?
4
McCullough:FYCalculatingFYDrugFYDosages3rde,FY3rde
1
,Castillo/Werner-
McCullough:FYCalculatingFYDrugFYDosages3rde,FY3rde
2
,Castillo/Werner-
McCullough:FYCalculatingFYDrugFYDosages3rde,FY3rde
ChapterFY1:FYSafetyFYinFYMedicationFYAdministration
Castillo:FYCalculatingFYDrugFYDosages:FYAFYPatient-
SafeFYApproachFYtoFYNursingFYandFYMathFY3rdFYEdition
MULTIPLEFYCHOICE
1. TheFYfollowingFYmedicationFYorderFYisFYinFYtheFYpatient’sFYmedicationFYadministrationFYrecordFY(MA
R):
methylPREDnisoloneFY40FYmgFYPOFYdailyFYatFY0900.
AfterFYreadingFYtheFYorder,FYtheFYnurseFYcorrectlyFYdetermines:
A “PO”FYisFYanFYinappropriateFYabbreviation.
B theFYmedicationFYorderFYisFYwrittenFYcorrectly.
C 40FYmgFYshouldFYbeFYwrittenFYasFY40mg.
D tallFYmanFYletteringFYindicatesFYthatFYtheFYdrugFYisFYaFYnarc
otic.
ANSWER:FYB
Feedback
TheFYmedicationFYorderFYhasFYallFYtheFYrequiredFYcomponentsFY(drugFYname,FYdose,FYro
ute,FYandFYfrequencyFYofFYadministration)FYforFYaFYdrugFYorder.FY“PO”FYisFYanFYappropria
teFYabbreviation;FY40FYmgFYisFYwrittenFYcorrectlyFYwithFYaFYspaceFYbetweenFYtheFYdoseFYa
ndFYtheFYunitFYofFYmeasurement.FYTallFYmanFYletteringFYisFYusedFYtoFYdistinguishFYtheFYd
rugFYfromFYanotherFYdrug
withFYaFYsimilarFYname.
2. WhichFYofFYtheFYfollowingFYaccuratelyFYdescribesFYtheFY“BoxedFYWarning”FYfoundFYonFYaFYdrugFYlabel
?
A ItFYisFYprimarilyFYisFYusedFYtoFYidentifyFYtheFYsafeFYdoseFYforFYtheFYpatient.
B ItFYisFYcommonlyFYfoundFYonFYallFYdrugFYlabels.
C ItFYidentifiesFYseriousFYpotentialFYrisksFYandFYsideFYeffectsFYrelatedFYtoFYdrugFY
use.
D ItFYprotectsFYtheFYpatientFYbyFYprovidingFYinformationFYtoFYdecreaseFYsideFYef
fects.
ANSWER:FYC
Feedback
3
, Castillo/Werner-
McCullough: FYCalculatingFYDrugFYDosages3rde,FY3rde
AFYdrug FYlabelFYwithFYaFYboxedFYwarningFYprovidesFYinformationFYtoFYhealthcareFYprofe
ssionalsFYandFYpatientsFYregardingFYtheFYseriousFYrisksFYandFYsideFYeffectsFYrelatedFYtoFYth
eFYdrug.FYTheFYBoxedFYWarningFYisFYnotFYtheFYprimaryFYsourceFYforFYidentifyingFYtheFYp
atient’sFYdrugFYdosage.
TheFYwarningFYisFYfoundFYonFYspecificFYprescriptionFYmedicationsFYandFYdoesFYnotFY
provideFYinformationFYtoFYreduceFYorFYdecreaseFYsideFYeffects.
3. WhenFYpracticingFYsafetyFYinFYtheFYadministrationFYofFYmedication,FYforFYwhichFYofFYtheFYf
ollowingFYmedicationFYordersFYshouldFYaFYnurseFYseekFYclarificationFYbeforeFYtheFYadminist
rationFYofFYtheFYmedication?
4